Prevalence and causes of vision loss in central Tanzania.

PubWeight™: 2.02‹?› | Rank: Top 2%

🔗 View Article (PMID 2022439)

Published in Int Ophthalmol on March 01, 1991

Authors

P A Rapoza1, S K West, S J Katala, H R Taylor

Author Affiliations

1: Department of Ophthalmology, University of Wisconsin-Madison.

Articles citing this

Epidemiology and aetiological diagnosis of corneal ulceration in Madurai, south India. Br J Ophthalmol (1997) 4.52

Blindness in Africa: present situation and future needs. Br J Ophthalmol (2001) 2.81

The Bhaktapur eye study: ocular trauma and antibiotic prophylaxis for the prevention of corneal ulceration in Nepal. Br J Ophthalmol (2001) 2.28

Evaluation of barriers to surgical compliance in the treatment of trichiasis. Int Ophthalmol (1998) 1.84

Prevalence of eye diseases in primary school children in a rural area of Tanzania. Br J Ophthalmol (2000) 1.66

Prevalence and causes of blindness and low vision in southern Sudan. PLoS Med (2006) 1.54

Increase in mortality associated with blindness in rural Africa. Bull World Health Organ (1991) 1.17

Prevalence of blindness and low vision of people over 30 years in the Wenchi district, Ghana, in relation to eye care programmes. Br J Ophthalmol (1994) 1.15

Epidemiological characteristics of microbiological results on patients with infectious corneal ulcers: a 13-year survey in Paraguay. Graefes Arch Clin Exp Ophthalmol (2004) 1.12

Epidemiology of glaucoma in sub-saharan Africa: prevalence, incidence and risk factors. Middle East Afr J Ophthalmol (2013) 1.10

A randomised clinical trial comparing 2% econazole and 5% natamycin for the treatment of fungal keratitis. Br J Ophthalmol (2003) 1.10

Microbial keratitis in East Africa: why are the outcomes so poor? Ophthalmic Epidemiol (2011) 0.88

Epidemiology of blindness and visual impairment in the kingdom of Tonga. Br J Ophthalmol (1994) 0.86

Risk factors for visual impairment associated with corneal diseases in southern China. Clin Ophthalmol (2016) 0.75

Progress of Trachoma Mapping in Mainland Tanzania: Results of Baseline Surveys from 2012 to 2014. Ophthalmic Epidemiol (2016) 0.75

Articles by these authors

A simple system for the assessment of trachoma and its complications. Bull World Health Organ (1987) 12.27

Blindness and visual impairment in southern Malawi. Bull World Health Organ (1986) 6.07

Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis. J Immunol (1987) 5.64

Azithromycin in control of trachoma. Lancet (1999) 4.32

The ecology of trachoma: an epidemiological study in southern Mexico. Bull World Health Organ (1985) 3.91

Effect of ultraviolet radiation on cataract formation. N Engl J Med (1988) 3.59

Trachoma: evaluation of a new grading scheme in the United Republic of Tanzania. Bull World Health Organ (1987) 3.48

The prevalence of glaucoma in a population-based study of Hispanic subjects: Proyecto VER. Arch Ophthalmol (2001) 3.31

A controlled trial of surgery for trachomatous trichiasis of the upper lid. Arch Ophthalmol (1992) 3.28

Age-standardization in epidemiological data. Int J Epidemiol (1994) 3.17

Impact of face-washing on trachoma in Kongwa, Tanzania. Lancet (1995) 3.06

Clinical grading and the effects of scaling. Invest Ophthalmol Vis Sci (1991) 2.89

Assessment of neonatal conjunctivitis with a direct immunofluorescent monoclonal antibody stain for Chlamydia. JAMA (1986) 2.69

A comprehensive assessment of visual impairment in a population of older Americans. The SEE Study. Salisbury Eye Evaluation Project. Invest Ophthalmol Vis Sci (1997) 2.64

The prevalence of glaucoma in the Melbourne Visual Impairment Project. Ophthalmology (1998) 2.63

The environment and the lens. Br J Ophthalmol (1980) 2.59

The epidemiology of dry eye in Melbourne, Australia. Ophthalmology (1998) 2.58

Prevalence of glaucoma in a rural East African population. Invest Ophthalmol Vis Sci (2000) 2.50

Hygiene factors and increased risk of trachoma in central Tanzania. Arch Ophthalmol (1989) 2.45

Causes of blindness and visual impairment in a population of older Americans: The Salisbury Eye Evaluation Study. Arch Ophthalmol (2000) 2.45

Pathogenesis of trachoma: the stimulus for inflammation. J Immunol (1987) 2.34

Cataract: how much surgery do we have to do? Br J Ophthalmol (2000) 2.34

Diabetic retinopathy: examination practices and referral patterns of general practitioners. Med J Aust (1996) 2.19

An animal model of trachoma II. The importance of repeated reinfection. Invest Ophthalmol Vis Sci (1982) 2.16

Exposure to sunlight and other risk factors for age-related macular degeneration. Arch Ophthalmol (1989) 2.16

Risk factors for constant, severe trachoma among preschool children in Kongwa, Tanzania. Am J Epidemiol (1996) 2.03

The excimer laser in Australia. Med J Aust (1992) 2.01

The epidemiology of cataract in Australia. Am J Ophthalmol (1999) 2.01

Age-specific causes of bilateral visual impairment. Arch Ophthalmol (2000) 1.98

Vision impairment predicts 5 year mortality. Br J Ophthalmol (2001) 1.98

Prevalence and risk factors of myopia in Victoria, Australia. Arch Ophthalmol (1999) 1.95

The epidemiology of trachoma in central Tanzania. Int J Epidemiol (1991) 1.93

Cause-specific prevalence of bilateral visual impairment in Victoria, Australia: the Visual Impairment Project. Ophthalmology (2001) 1.90

Risk factors for age-related maculopathy: the Visual Impairment Project. Arch Ophthalmol (2001) 1.88

The heritability of age-related cortical cataract: the twin eye study. Invest Ophthalmol Vis Sci (2001) 1.88

An immunogenic Onchocerca volvulus antigen: a specific and early marker of infection. Science (1991) 1.86

Evaluation of barriers to surgical compliance in the treatment of trichiasis. Int Ophthalmol (1998) 1.84

Ocular exposure to UV-B in sunlight: the Melbourne visual impairment project model. Bull World Health Organ (1996) 1.83

Impact of unilateral and bilateral vision loss on quality of life. Br J Ophthalmol (2005) 1.82

Blindness due to cataract: epidemiology and prevention. Annu Rev Public Health (1996) 1.80

Visual and medical risk factors for motor vehicle collision involvement among older drivers. Br J Ophthalmol (2008) 1.79

Demonstration of chlamydial RNA and DNA during a culture-negative state. Infect Immun (1992) 1.77

Five-year incidence and disappearance of drusen and retinal pigment epithelial abnormalities. Waterman study. Arch Ophthalmol (1995) 1.76

Resuturing following penetrating keratoplasty: a retrospective analysis. Br J Ophthalmol (2008) 1.75

Long term outcome of trichiasis surgery in the Gambia. Br J Ophthalmol (2005) 1.73

The prevalence of glaucoma among Eskimos of northwest Alaska. Arch Ophthalmol (1987) 1.72

Senile lens changes and diabetes in two population studies. Am J Ophthalmol (1981) 1.69

Eye care utilization by older Americans: the SEE Project. Salisbury Eye Evaluation. Ophthalmology (1999) 1.69

Methods for a population-based study of eye disease: the Melbourne Visual Impairment Project. Ophthalmic Epidemiol (1994) 1.69

The effect of prescription eyewear on ocular exposure to ultraviolet radiation. Am J Public Health (1986) 1.65

International ophthalmology strategic plan to preserve and restore vision-vision for the future. Am J Ophthalmol (2001) 1.65

The prevalence of age-related maculopathy: the visual impairment project. Ophthalmology (2000) 1.64

The ocular dose of ultraviolet radiation from sunlight exposure. Photochem Photobiol (1985) 1.64

The association of multiple visual impairments with self-reported visual disability: SEE project. Invest Ophthalmol Vis Sci (2001) 1.64

Plasma antioxidants and risk of cortical and nuclear cataract. Epidemiology (1993) 1.63

The effect of early cataracts on glare and contrast sensitivity. A pilot study. Arch Ophthalmol (1992) 1.61

Water availability and trachoma. Bull World Health Organ (1989) 1.61

Corneal changes associated with chronic UV irradiation. Arch Ophthalmol (1989) 1.59

Detection of hepatitis B virus DNA in tears by polymerase chain reaction. Arch Ophthalmol (1994) 1.57

Prevalence and predictors of undercorrected refractive errors in the Victorian population. Am J Ophthalmol (1999) 1.56

Perforating ocular fishhook injury. Arch Ophthalmol (1992) 1.54

Schizophrenia, psychotropic medication, and cataract. Ophthalmology (1999) 1.54

The grading and prevalence of macular degeneration in Chesapeake Bay watermen. Arch Ophthalmol (1989) 1.53

Epidemiology of ocular trauma in Australia. Ophthalmology (1999) 1.50

Pseudoexfoliation syndrome in Australian adults. Am J Ophthalmol (2000) 1.48

Knowledge, attitudes, and self care practices associated with age related eye disease in Australia. Br J Ophthalmol (1998) 1.46

Pterygium surgery in Victoria: a survey of ophthalmologists. Aust N Z J Ophthalmol (1998) 1.45

The ocular dose of ultraviolet radiation to outdoor workers. Invest Ophthalmol Vis Sci (1988) 1.44

An animal model for cicatrizing trachoma. Invest Ophthalmol Vis Sci (1981) 1.44

Blindness and visual impairment in the Americas and the Caribbean. Br J Ophthalmol (2002) 1.44

A systematic approach to the diagnosis and treatment of chronic conjunctivitis. Am J Ophthalmol (1990) 1.43

Epidemiology of corneal blindness in developing countries. Refract Corneal Surg (1992) 1.43

The epidemiology of trachoma in southern Malawi. Am J Trop Med Hyg (1988) 1.41

Epidemiology of pterygium in Victoria, Australia. Br J Ophthalmol (2000) 1.41

Monocular versus binocular visual acuity as measures of vision impairment and predictors of visual disability. Invest Ophthalmol Vis Sci (2000) 1.41

Management of alkali burns : an 11-year retrospective review. Ophthalmology (2000) 1.40

Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis. N Engl J Med (1985) 1.39

Blindness and trachoma in South Australia. Aust N Z J Ophthalmol (1995) 1.39

Controlled study of the use of autologous serum in dry eye patients. Cornea (2001) 1.39

A comparison of participants with non-participants in a population-based epidemiologic study: the Melbourne Visual Impairment Project. Ophthalmic Epidemiol (1997) 1.38

Application of the verbal autopsy during a clinical trial. Soc Sci Med (1990) 1.38

Cholesterol-lowering medications reduce the risk of age-related maculopathy progression. Med J Aust (2001) 1.38

Prevalence and predictors of open-angle glaucoma: results from the visual impairment project. Ophthalmology (2001) 1.38

Self-reported assessment of dry eye in a population-based setting. Invest Ophthalmol Vis Sci (1997) 1.37

Use of eye care services by people with diabetes: the Melbourne Visual Impairment Project. Br J Ophthalmol (1998) 1.37

Ocular and facial skin exposure to ultraviolet radiation in sunlight: a personal exposure model with application to a worker population. Health Phys (1991) 1.37

Characteristics of discrepancies between self-reported visual function and measured reading speed. Salisbury Eye Evaluation Project Team. Invest Ophthalmol Vis Sci (1999) 1.35

Diabetic retinopathy in Victoria, Australia: the Visual Impairment Project. Br J Ophthalmol (2000) 1.34

Retinal detachment risk in cytomegalovirus retinitis related to the acquired immunodeficiency syndrome. Arch Ophthalmol (2001) 1.34

Cellular killing of microfilariae of Onchocerca volvulus: eosinophil and neutrophil-mediated immune serum-dependent destruction. J Immunol (1981) 1.34

Trichiasis and disability in a trachoma-endemic area of Tanzania. Arch Ophthalmol (2001) 1.33

The epidemiology of cataract: a review of the literature. Ophthalmic Epidemiol (1995) 1.33

Long term results of glaucoma surgery among participants in an east African population survey. Br J Ophthalmol (2000) 1.32

Risk factors for trachoma: 6-year follow-up of children aged 1 and 2 years. Am J Epidemiol (2000) 1.32